Home

Torrent Pharmaceuticals Ltd PE Ratio

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

PE

55.4

Last updated on: Feb 19, 2025

Key Highlights

  • The P/E Ratio of Torrent Pharmaceuticals Ltd is 55.4 as of 19 Feb 14:46 PM .
  • The P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Latest Trading Price of Torrent Pharmaceuticals Ltd is ₹ 3108 as of 19 Feb 14:36 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Torrent Pharmaceuticals Ltd

No data available

Company Fundamentals for Torrent Pharmaceuticals Ltd

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

Share Price

₹ 3108.75

62.45 (2.05%)

stock direction

Last updated on: Feb 19, 2025

Market Price of Torrent Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Feb 20253046.3
17 Feb 20253077.05
14 Feb 20253011.5
13 Feb 20253074.75
12 Feb 20253063.05
11 Feb 20253104.95
10 Feb 20253190.6
07 Feb 20253259.4
06 Feb 20253161.35
05 Feb 20253115.7

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Torrent Pharmaceuticals Ltd

Asset Value vs Market Value of Torrent Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Torrent Pharmaceuticals Ltd103096
Sun Pharmaceuticals Industries Ltd408259
Divis Laboratories Ltd154917
Cipla Ltd119705
Dr Reddys Laboratories Ltd99951
Mankind Pharma Ltd98468

PE Ratio of Torrent Pharmaceuticals Ltd Explained

103096

Market cap

1862

Earnings

55.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Torrent Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Torrent Pharmaceuticals Ltd

No data available

* All values are in %

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.
  • Apart from this, it has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million.

Torrent Pharmaceuticals Ltd News Hub

Torrent Pharmaceuticals announces change in senior management

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Director from Vic

Read more

13 Aug 24

Torrent Pharma hits life as Gujarat unit gets EIR from USFDA

Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted a pre-app

Read more

30 Aug 24

Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion of the in

Read more

20 Sept 24

Torrent Pharmaceuticals announces board meeting date

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 October 2

Read more

10 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Torrent Pharmaceuticals Ltd

What is the current PE Ratio of Torrent Pharmaceuticals Ltd?

The Current PE Ratio of Torrent Pharmaceuticals Ltd is 55.37 as on 19 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 19 Feb 2025.

What was the PE Ratio of Torrent Pharmaceuticals Ltd last year?

The PE Ratio of Torrent Pharmaceuticals Ltd was 41.79 last year, now the PE ratio is 55.37, showing a year-on-year growth of 32.5%.

What does the PE Ratio of Torrent Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Torrent Pharmaceuticals Ltd is 55.37. This ratio indicates that investors are willing to pay 55.37 times the earnings per share for each share of Torrent Pharmaceuticals Ltd.

What is the PE Ratio Growth of Torrent Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Torrent Pharmaceuticals Ltd grew by 32.5% whereas, the EPS ratio grew by 11.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions